Vignesh Rajah

All filings by Vignesh Rajah on record concern Y-mAbs Therapeutics, Inc., in the capacity of senior executive. In total, 7 filings cover trades dated from 17 November 2020 to 5 March 2024.

On the open market, the record shows 4 purchases worth €107k and 1 sale worth €26k. Purchases outweigh sales by €81k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants. Since January 2024: no purchases and 1 sale on the market.

In size, the median ticket on the buying side is €22k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

The record was last updated on 7 March 2024 with an open-market sale (€26k) in Y-mAbs Therapeutics, Inc. The most recent open-market purchase was published on 16 November 2022, 1,455 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.